Number of bleeding sites reported based on platelet count
| No. of bleeding sites reported since last visit . | 6 mo following diagnosis* . | 12 mo following diagnosis* . | 24 mo following diagnosis* . | |||
|---|---|---|---|---|---|---|
| <20 × 109/L (%), n = 61 . | 20-150 × 109/L (%), n = 255 . | <20 × 109/L (%), n = 50 . | 20-150 × 109/L (%), n = 204 . | <20 × 109/L (%), n = 17 . | 20-150 × 109/L (%), n = 121 . | |
| None | 1 (2) | 90 (35) | 12 (24) | 96 (47) | 3 (18) | 65 (54) |
| 1 | 25 (41) | 105 (41) | 18 (36) | 77 (38) | 6 (35) | 35 (29) |
| 2 | 19 (31) | 46 (18) | 10 (20) | 25 (12) | 6 (35) | 15 (12) |
| ≥3 | 16 (26) | 14 (5) | 10 (20) | 6 (3) | 2 (12) | 6 (5) |
| No. of bleeding sites reported since last visit . | 6 mo following diagnosis* . | 12 mo following diagnosis* . | 24 mo following diagnosis* . | |||
|---|---|---|---|---|---|---|
| <20 × 109/L (%), n = 61 . | 20-150 × 109/L (%), n = 255 . | <20 × 109/L (%), n = 50 . | 20-150 × 109/L (%), n = 204 . | <20 × 109/L (%), n = 17 . | 20-150 × 109/L (%), n = 121 . | |
| None | 1 (2) | 90 (35) | 12 (24) | 96 (47) | 3 (18) | 65 (54) |
| 1 | 25 (41) | 105 (41) | 18 (36) | 77 (38) | 6 (35) | 35 (29) |
| 2 | 19 (31) | 46 (18) | 10 (20) | 25 (12) | 6 (35) | 15 (12) |
| ≥3 | 16 (26) | 14 (5) | 10 (20) | 6 (3) | 2 (12) | 6 (5) |
P < .05 for χ2; P < .05 test for trend.